Primerica (NYSE:PRI – Get Free Report) declared that its board has approved a stock buyback program on Thursday, November 14th, RTT News reports. The company plans to repurchase $450.00 million in outstanding shares. This repurchase authorization authorizes the financial services provider to reacquire up to 4.5% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.
Primerica Trading Up 0.6 %
Shares of NYSE PRI opened at $298.61 on Friday. Primerica has a 12-month low of $184.76 and a 12-month high of $304.84. The stock’s fifty day simple moving average is $273.65 and its two-hundred day simple moving average is $251.14. The stock has a market capitalization of $9.96 billion, a PE ratio of 22.80 and a beta of 1.08.
Primerica (NYSE:PRI – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The financial services provider reported $5.68 earnings per share for the quarter, beating analysts’ consensus estimates of $4.81 by $0.87. The company had revenue of $774.13 million for the quarter, compared to the consensus estimate of $745.25 million. Primerica had a return on equity of 30.93% and a net margin of 14.95%. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter last year, the company earned $4.28 earnings per share. On average, equities analysts predict that Primerica will post 19.12 earnings per share for the current fiscal year.
Primerica Dividend Announcement
Analyst Ratings Changes
Several research firms have issued reports on PRI. Morgan Stanley boosted their price objective on shares of Primerica from $257.00 to $269.00 and gave the company an “equal weight” rating in a research report on Monday, August 19th. StockNews.com lowered Primerica from a “buy” rating to a “hold” rating in a report on Thursday. TD Cowen began coverage on Primerica in a report on Wednesday, October 9th. They set a “buy” rating and a $314.00 price objective on the stock. Truist Financial lifted their target price on Primerica from $300.00 to $340.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Finally, Piper Sandler assumed coverage on Primerica in a research report on Friday, August 30th. They set a “neutral” rating and a $283.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $288.33.
Read Our Latest Research Report on Primerica
Insider Buying and Selling
In related news, Director John A. Jr. Addison sold 2,000 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $253.85, for a total value of $507,700.00. Following the completion of the transaction, the director now directly owns 15,151 shares of the company’s stock, valued at $3,846,081.35. This trade represents a 11.66 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Peter W. Schneider sold 1,500 shares of Primerica stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $261.11, for a total transaction of $391,665.00. Following the completion of the sale, the president now owns 10,259 shares of the company’s stock, valued at $2,678,727.49. This trade represents a 12.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,500 shares of company stock worth $1,803,175 in the last 90 days. 0.85% of the stock is owned by corporate insiders.
Primerica Company Profile
Primerica, Inc, together with its subsidiaries, provides financial products and services to middle-income households in the United States and Canada. The company operates in four segments: Term Life Insurance; Investment and Savings Products; Senior Health; and Corporate and Other Distributed Products.
Featured Articles
- Five stocks we like better than Primerica
- High Dividend REITs: Are They an Ideal Way to Diversify?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Invest in Biotech Stocks
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What Does a Stock Split Mean?
- Time to Load Up on Home Builders?
Receive News & Ratings for Primerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Primerica and related companies with MarketBeat.com's FREE daily email newsletter.